Together Pharma

Together Pharma Equity Growth

The Year-over-Year Equity Growth of Together Pharma (TGTR.TA) as of Oct 22, 2026 is 527.61 %. In the previous year, Year-over-Year Equity Growth was -1,729.34 % — a change of -130.51% (higher).

Equity Growth

527.61 %

YoY

-130.51%

Last updated:

Year-over-Year Equity Growth of Together Pharma is 2024 527.61 % . Year-over-Year Equity Growth of Together Pharma was 2023 -1,729.34 % . It decreases by -130.51% higher compared to the previous year.

The Together Pharma Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2017
-113.38 ILS
Jan 1, 2018
-16,950.43 ILS
Jan 1, 2019
63.49 ILS
Jan 1, 2020
176.30 ILS
Jan 1, 2021
148.86 ILS
Jan 1, 2022
-102.07 ILS
Jan 1, 2023
-1,729.34 ILS
Jan 1, 2024
527.61 ILS
The Together Pharma Equity Growth history
YEAREquity GrowthYoY
527.61 %-130.51%
-1,729.34 %+1,594.35%
-102.07 %-168.56%
148.86 %-15.57%
176.30 %+177.69%
63.49 %-100.37%
-16,950.43 %+14,849.72%
-113.38 %+68.09%
-67.45 %-109.45%
714.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Together Pharma Stock analysis

What does Together Pharma do? Together Pharma Ltd. operates through the multiplication, cultivation, production, storage, marketing, and distribution of medical products based on the cannabis plant. The company markets three specific digital products: ExactMe, which serves as a search engine for recruiters to find jobseekers; POP CV, a curriculum vitae center system that assesses, ranks, and matches resumes sent to employers; and SkilliQ, which functions as a job board. Together Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Together Pharma stock

Year-over-Year Equity Growth of Together Pharma is 527.61 % in 2024.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Together Pharma since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Together Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — Together Pharma

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Together Pharma